Signaturefd, LLC Ascendis Pharma A/S Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Signaturefd, LLC holds 686 shares of ASND stock, worth $93,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares

686

Previous 606 13.2%

Holding current value

$93,515

Previous $82,000 24.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$113.0 - $153.43 $9,040 - $12,274	80 Added 13.2%	686 $102,000
Q2 2024 Jul 29, 2024	SELL	$121.07 - $153.67 $5,569 - $7,068	-46 Reduced 7.06%	606 $82,000
Q1 2024 May 03, 2024	BUY	$123.45 - $159.4 $10,987 - $14,186	89 Added 15.81%	652 $98,000
Q4 2023 Jan 31, 2024	SELL	$86.1 - $127.36 $20,233 - $29,929	-235 Reduced 29.45%	563 $70,000
Q3 2023 Nov 03, 2023	BUY	$86.5 - $103.97 $16,694 - $20,066	193 Added 31.9%	798 $74,000
Q2 2023 Aug 01, 2023	SELL	$69.96 - $97.84 $47,013 - $65,748	-672 Reduced 52.62%	605 $53,000
Q1 2023 Apr 28, 2023	SELL	$104.9 - $126.78 $6,713 - $8,113	-64 Reduced 4.77%	1,277 $136,000
Q4 2022 Jan 27, 2023	BUY	$99.42 - $131.97 $4,871 - $6,466	49 Added 3.79%	1,341 $163,000
Q3 2022 Nov 08, 2022	BUY	$84.03 - $110.23 $42,015 - $55,115	500 Added 63.13%	1,292 $133,000
Q2 2022 Aug 10, 2022	BUY	$78.08 - $117.61 $41,304 - $62,215	529 Added 201.14%	792 $74,000
Q1 2022 May 02, 2022	SELL	$102.18 - $135.75 $40,156 - $53,349	-393 Reduced 59.91%	263 $31,000
Q4 2021 Jan 25, 2022	SELL	$127.1 - $169.66 $254 - $339	-2 Reduced 0.3%	656 $88,000
Q3 2021 Oct 28, 2021	BUY	$112.67 - $176.92 $19,829 - $31,137	176 Added 36.51%	658 $105,000
Q2 2021 Jul 26, 2021	BUY	$121.62 - $145.29 $15,202 - $18,161	125 Added 35.01%	482 $63,000
Q1 2021 Apr 30, 2021	BUY	$124.92 - $173.33 $9,244 - $12,826	74 Added 26.15%	357 $46,000
Q4 2020 Feb 11, 2021	BUY	$151.2 - $182.76 $9,223 - $11,148	61 Added 27.48%	283 $47,000
Q3 2020 Nov 03, 2020	BUY	$134.29 - $154.32 $19,740 - $22,685	147 Added 196.0%	222 $34,000
Q2 2020 Jul 30, 2020	BUY	$110.87 - $156.01 $4,767 - $6,708	43 Added 134.38%	75 $11,000
Q1 2020 Apr 23, 2020	BUY	$97.01 - $145.11 $3,104 - $4,643	32 New	32 $4,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account